pentamidine has been researched along with Alloxan Diabetes in 2 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saï, P | 1 |
| Boillot, D | 1 |
| Boitard, C | 1 |
| Debray-Sachs, M | 1 |
| Reach, G | 1 |
| Assan, R | 1 |
| Yurdakök, M | 1 |
2 other studies available for pentamidine and Alloxan Diabetes
| Article | Year |
|---|---|
Pentamidine, a new diabetogenic drug in laboratory rodents.
Topics: Amidines; Animals; Diabetes Mellitus, Experimental; Insulin; Insulin Secretion; Islets of Langerhans | 1983 |
Diabetogenic effect of pentamidine.
Topics: Amidines; Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Mice; Pentamidine | 1987 |